Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ophthotech
Ophthotech
3 Biotechs That Play Well with Others
Motley Fool
Thu, 10/1/15 - 09:39 am
Ophthotech
Halozyme
Portola
The Next Blockbusters Could Be Balms For Aging Eyes
Investors.com
Thu, 09/3/15 - 09:10 am
age-related macular degeneration
Bayer
Regeneron
Ophthotech
Allergan
Novartis
Applied Genetic Technologies
Avalanche Biotechnologies
Roche
Lucentis
Eylea
5 Drugs That Investors May Be Undervaluing
Motley Fool
Mon, 07/13/15 - 11:04 am
Amicus Therapeutics
Galafold
Receptos
ozanimod
GS-5816
Gilead Sciences
ACH-3102
Achillion
Ophthotech
Fovista
3 Little-Known Biotechs Working On Potential Blockbusters
Motley Fool
Sun, 03/29/15 - 11:42 am
Ophthotech
Fovista
Esperion Therapeutics. ETC-1002
Prothena
PRX-002
2 Tiny Biotechs That Could Have Blockbuster Opportunity
Motley Fool
Sat, 03/7/15 - 11:23 am
Ophthotech
Fovista
Portola Pharmaceuticals
This Tiny Biotech Hopes to Capture a Share of This $6 Billion Market
Motley Fool
Mon, 02/2/15 - 10:08 am
Ophthotech
Novartis
Regeneron
Fovista
Roche
Avastin
Eylea
Lucentis
wet age-related macular degeneration
Ophthotech deal with Novartis leaves Fovista well-positioned, says Stifel
The Fly on the Wall
Tue, 05/20/14 - 11:24 am
Ophthotech
Fovista
Novartis
wet age-related macular degeneration
wet-AMD
How The Global Pharma Industry Will Shape Up In The Next 5 Years?
Seeking Alpha
Wed, 12/4/13 - 11:38 am
Bristol-Myers Squibb
GSK
JNJ
Ophthotech
Novartis
Regeneron
Roche
Sanofi
Fresh burst of biotech IPO pitches launches a busy Q4 season
Fierce Biotech
Tue, 10/22/13 - 11:51 am
IPOs
Foundation Medicine
Ophthotech
Intrexon
Onconova
Agios
OncoMed
Ophthotech, Foundation Medicine loot booming biotech IPO market for $273M
Fierce Biotech
Wed, 09/25/13 - 09:29 am
Ophthotech
IPOs
Foundation Medicine
Ophthotech eyes $85M IPO to fund PhIII for drug to prevent blindness
Fierce Biotech
Fri, 08/16/13 - 10:52 am
wet age-related macular degeneration
Ophthotech
IPOs
Regeneron drops 6% after Ophthotech reports positive data
The Fly on the Wall
Wed, 06/13/12 - 12:01 pm
Ophthotech
Regeneron
Roche
Lucentis
Fovista
Eylea
wet-AMD
Pages
« first
‹ previous
1
2